Menu Search
Equities

Procter & Gamble Co

PG-RM:MCX

Procter & Gamble Co

Actions
  • Price (--)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
--
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, baby stores, specialty beauty stores, e-commerce, high-frequency stores, pharmacies, electronics stores and professional channels. It offers products under the brands, such as Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret, SK-II, Braun, Gillette, Venus, Crest, Oral-B, Metamucil, Neurobion, Pepto-Bismol, Vicks, Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer, Luvs, Pampers, Always, Always Discreet, Tampax, Bounty, Charmin and Puffs.

  • Revenue in USD (TTM)79.62bn
  • Net income in USD14.31bn
  • Incorporated1905
  • Employees3.00k
  • Location
    Procter & Gamble Co1 Procter and Gamble PlzCINCINNATI 45202-3315United StatesUSA
  • Phone+1 (513) 983-1100
  • Fax+1 (513) 983-4381
  • Websitehttps://us.pg.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		PG:NYQ since
announced		Transaction
value
TULA Life IncAnnounced04 Jan 202204 Jan 2022Announced-12.96%--
OUAI Holding LLCDeal completed07 Dec 202107 Dec 2021Deal completed-6.81%--
Farmacy BeautyDeal completed15 Nov 202115 Nov 2021Deal completed-3.25%--
Data delayed at least 15 minutes, as of May 20 2022 21:10 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.